European stock markets edged higher on Monday, supported by optimism over a historic German debt deal, which investors hope will revive economic growth in Europe.
- DAX (Germany): +0.4%
- CAC 40 (France): +0.3%
- FTSE 100 (UK): +0.1%
Germany’s Debt Expansion Plans Drive Optimism
- Friedrich Merz, expected to be Germany’s next chancellor, struck a deal with the Greens to increase state borrowing for defense and infrastructure.
- This move marks one of the biggest fiscal shifts since 1989 and would require a constitutional amendment.
- The Bundestag vote on Tuesday needs a two-thirds majority for approval.
- DAX Year-to-Date Gain: +15% as investor confidence surges.
U.S.-EU Trade War Escalates
- The EU retaliated against Trump’s 25% tariffs on steel and aluminum, imposing countermeasures on U.S. goods like clothing, alcohol, and industrial products.
- In response, Trump threatened a 200% tariff on champagne and European spirits.
- ECB Vice President Luis de Guindos warned that Trump’s trade policies have clouded global economic outlooks.
AstraZeneca’s $1 Billion Biotech Acquisition
- AstraZeneca (LON:AZN) stock fell 0.8% after it announced plans to acquire EsoBiotec for up to $1 billion.
- The deal aims to strengthen its cell therapy portfolio, particularly in cancer and autoimmune diseases.
Oil Prices Rise on U.S. Strikes Against Houthis
- Brent crude: +0.9% to $71.18/barrel
- WTI crude: +0.9% to $67.50/barrel
- The U.S. launched airstrikes on Yemen’s Houthi rebels, responding to attacks on Red Sea shipping lanes.
- The Red Sea accounts for 15% of global shipping, and further conflict may disrupt supply chains.
Upcoming Geopolitical Developments
- Trump to speak with Putin on Tuesday, seeking progress on a Russia-Ukraine ceasefire.
Despite trade tensions and geopolitical risks, European stocks remain buoyant, with Germany’s fiscal reset offering potential economic support for the region.